Blink and you'll see it: how to detect Ca2+ quarks.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 21252146)

Published in Circ Res on January 21, 2011

Authors

Niall Macquaide, Karin R Sipido

Articles cited by this

Quarky calcium release in the heart. Circ Res (2010) 1.75

Articles by these authors

Reduced synchrony of Ca2+ release with loss of T-tubules-a comparison to Ca2+ release in human failing cardiomyocytes. Cardiovasc Res (2004) 3.10

Probing the contribution of IKs to canine ventricular repolarization: key role for beta-adrenergic receptor stimulation. Circulation (2003) 2.06

Can body surface microvolt T-wave alternans distinguish concordant and discordant intracardiac alternans? Pacing Clin Electrophysiol (2013) 2.04

Early exercise training normalizes myofilament function and attenuates left ventricular pump dysfunction in mice with a large myocardial infarction. Circ Res (2007) 1.71

Transcriptome characterization of estrogen-treated human myocardium identifies myosin regulatory light chain interacting protein as a sex-specific element influencing contractile function. J Am Coll Cardiol (2012) 1.56

Increased phospholamban phosphorylation limits the force-frequency response in the MLP-/- mouse with heart failure. J Mol Cell Cardiol (2006) 1.49

Accumulation of slowly activating delayed rectifier potassium current (IKs) in canine ventricular myocytes. J Physiol (2003) 1.39

Microvolt T-wave alternans and beat-to-beat variability of repolarization during early postischemic remodeling in a pig heart. Heart Rhythm (2011) 1.38

Ultrastructural and functional remodeling of the coupling between Ca2+ influx and sarcoplasmic reticulum Ca2+ release in right atrial myocytes from experimental persistent atrial fibrillation. Circ Res (2009) 1.38

Sudden death of a young adult associated with Bacillus cereus food poisoning. J Clin Microbiol (2011) 1.32

Intracellular Na in animal models of hypertrophy and heart failure: contractile function and arrhythmogenesis. Cardiovasc Res (2003) 1.23

Pharmacological inhibition of na/ca exchange results in increased cellular Ca2+ load attributable to the predominance of forward mode block. Circ Res (2008) 1.20

Crosstalk between L-type Ca2+ channels and the sarcoplasmic reticulum: alterations during cardiac remodelling. Cardiovasc Res (2007) 1.20

Microdomain [Ca²⁺] near ryanodine receptors as reported by L-type Ca²⁺ and Na+/Ca²⁺ exchange currents. J Physiol (2011) 1.18

Mechanisms underlying the frequency dependence of contraction and [Ca(2+)](i) transients in mouse ventricular myocytes. J Physiol (2002) 1.17

Selective inhibition of Cx43 hemichannels by Gap19 and its impact on myocardial ischemia/reperfusion injury. Basic Res Cardiol (2012) 1.17

ATP and PIP2 dependence of the magnesium-inhibited, TRPM7-like cation channel in cardiac myocytes. Am J Physiol Cell Physiol (2006) 1.15

Spatial and temporal inhomogeneities during Ca2+ release from the sarcoplasmic reticulum in pig ventricular myocytes. Circ Res (2002) 1.14

S100A1 decreases calcium spark frequency and alters their spatial characteristics in permeabilized adult ventricular cardiomyocytes. Cell Calcium (2006) 1.07

Na+/Ca2+ exchange and Na+/K+-ATPase in the heart. J Physiol (2015) 1.06

The effect of exercise training on transverse tubules in normal, remodeled, and reverse remodeled hearts. J Cell Physiol (2011) 1.05

Window Ca2+ current and its modulation by Ca2+ release in hypertrophied cardiac myocytes from dogs with chronic atrioventricular block. J Physiol (2006) 1.03

Intracellular Na+ and altered Na+ transport mechanisms in cardiac hypertrophy and failure. J Mol Cell Cardiol (2003) 1.01

Magnesium-inhibited, TRPM6/7-like channel in cardiac myocytes: permeation of divalent cations and pH-mediated regulation. J Physiol (2004) 0.99

[Na(+)] in the subsarcolemmal 'fuzzy' space and modulation of [Ca(2+)](i) and contraction in cardiac myocytes. Cell Calcium (2004) 0.97

Connexin mimetic peptides inhibit Cx43 hemichannel opening triggered by voltage and intracellular Ca2+ elevation. Basic Res Cardiol (2012) 0.97

The continuum of personalized cardiovascular medicine: a position paper of the European Society of Cardiology. Eur Heart J (2014) 0.97

Pharmacological modulation of connexin-formed channels in cardiac pathophysiology. Br J Pharmacol (2011) 0.95

Mechanisms of postsystolic thickening in ischemic myocardium: mathematical modelling and comparison with experimental ischemic substrates. Ultrasound Med Biol (2007) 0.95

A SERCA2 pump with an increased Ca2+ affinity can lead to severe cardiac hypertrophy, stress intolerance and reduced life span. J Mol Cell Cardiol (2006) 0.94

Combined Na(+)/Ca(2+) exchanger and L-type calcium channel block as a potential strategy to suppress arrhythmias and maintain ventricular function. Circ Arrhythm Electrophysiol (2013) 0.93

Subcellular heterogeneity of ryanodine receptor properties in ventricular myocytes with low T-tubule density. PLoS One (2011) 0.93

Increased Na+ concentration and altered Na/K pump activity in hypertrophied canine ventricular cells. Cardiovasc Res (2003) 0.92

Alternative strategies in arrhythmia therapy: evaluation of Na/Ca exchange as an anti-arrhythmic target. Pharmacol Ther (2011) 0.92

Temporal patterns of electrical remodeling in canine ventricular hypertrophy: focus on IKs downregulation and blunted beta-adrenergic activation. Cardiovasc Res (2006) 0.90

Activation of the cardiac Na(+)-Ca(2+) exchanger by sorcin via the interaction of the respective Ca(2+)-binding domains. J Mol Cell Cardiol (2010) 0.90

Reversible and irreversible differentiation of cardiac fibroblasts. Cardiovasc Res (2013) 0.89

Reduced force generating capacity in myocytes from chronically ischemic, hibernating myocardium. Circ Res (2007) 0.89

Cellular mechanisms of contractile dysfunction in hibernating myocardium. Circ Res (2004) 0.89

Exercise training does not improve cardiac function in compensated or decompensated left ventricular hypertrophy induced by aortic stenosis. J Mol Cell Cardiol (2011) 0.89

Channels involved in transient currents unmasked by removal of extracellular calcium in cardiac cells. Am J Physiol Heart Circ Physiol (2002) 0.89

Something old, something new: changing views on the cellular mechanisms of heart failure. Cardiovasc Res (2005) 0.88

Selective modulation of coupled ryanodine receptors during microdomain activation of calcium/calmodulin-dependent kinase II in the dyadic cleft. Circ Res (2013) 0.88

Understanding cardiac alternans: the answer lies in the Ca2+ store. Circ Res (2004) 0.88

Role of nitric oxide and oxidative stress in a sheep model of persistent atrial fibrillation. Europace (2013) 0.86

Early exercise training after myocardial infarction prevents contractile but not electrical remodelling or hypertrophy. Cardiovasc Res (2009) 0.86

Cellular basis for triggered ventricular arrhythmias that occur in the setting of compensated hypertrophy and heart failure: considerations for diagnosis and treatment. J Electrocardiol (2007) 0.86

Targeting calcium handling in arrhythmias. Europace (2008) 0.86

Targeting sarcoplasmic reticulum Ca2+ uptake to improve heart failure: hit or miss. Circ Res (2010) 0.85

Unilateral arm strength training improves contralateral peak force and rate of force development. Eur J Appl Physiol (2008) 0.85

Ca2+ uptake by the sarcoplasmic reticulum in ventricular myocytes of the SERCA2b/b mouse is impaired at higher Ca2+ loads only. Circ Res (2003) 0.84

Phospholamban ablation in hearts expressing the high affinity SERCA2b isoform normalizes global Ca²⁺ homeostasis but not Ca²⁺-dependent hypertrophic signaling. Am J Physiol Heart Circ Physiol (2012) 0.83

Mind the model: effect of instrumentation on inducibility of atrial fibrillation in a sheep model. J Cardiovasc Electrophysiol (2002) 0.83

T-tubule remodelling and ryanodine receptor organization modulate sodium-calcium exchange. Adv Exp Med Biol (2013) 0.83

Identifying needs and opportunities for advancing translational research in cardiovascular disease. Cardiovasc Res (2009) 0.82

Inhibition of the calcium-activated chloride current in cardiac ventricular myocytes by N-(p-amylcinnamoyl)anthranilic acid (ACA). Biochem Biophys Res Commun (2010) 0.82

What does the future hold for Cardiovascular Research? Cardiovasc Res (2012) 0.81

Non-invasive characterization of the area-at-risk using magnetic resonance imaging in chronic ischaemia. Cardiovasc Res (2010) 0.80

Cardiac FKBP12.6 overexpression protects against triggered ventricular tachycardia in pressure overloaded mouse hearts. Basic Res Cardiol (2012) 0.79

T-tubules and ryanodine receptor microdomains: on the road to translation. Cardiovasc Res (2013) 0.79

Sodium calcium exchange in the heart: necessity or luxury? Circ Res (2004) 0.79

Triggering controversy in cardiac excitation-contraction coupling. J Mol Cell Cardiol (2003) 0.78

Highlights of the 2007 scientific sessions of the European Society of Cardiology Vienna, Austria, September 1-5, 2007. J Am Coll Cardiol (2007) 0.77

CaM or cAMP: linking beta-adrenergic stimulation to 'leaky' RyRs. Circ Res (2007) 0.76

Nitric oxide delays atrial tachycardia-induced electrical remodelling in a sheep model. Europace (2011) 0.76

Cyclosporine A reduces microvascular obstruction and preserves left ventricular function deterioration following myocardial ischemia and reperfusion. Basic Res Cardiol (2015) 0.76

Alterations in excitation-contraction coupling in chronically ischemic or hibernating myocardium. Exp Clin Cardiol (2005) 0.76

Myocardial hibernation: a double-edged sword. Circ Res (2004) 0.75

Impairment of trafficking by downregulation of an anchor protein: novel insights into additional mechanisms responsible for heart failure. Heart Rhythm (2012) 0.75

Dofetilide as activator of Na/Ca exchange: new perspectives on an 'old' drug. Editorial to: "Dofetilide enhances the contractility of rat ventricular myocytes via augmentation of Na+-Ca 2+ exchange" by Xuan-Ping Zhang et al. Cardiovasc Drugs Ther (2009) 0.75

How old is your heart? Circ Res (2007) 0.75

Swallowing a spider to catch a fly: Ca-calmodulin dynamics in adult cardiomyocytes. J Mol Cell Cardiol (2006) 0.75

Nonexcitatory stimulation as a novel treatment for heart failure: cause for excitement? Eur Heart J (2004) 0.75

ACE-inhibition, but not weight reduction restores cardiomyocyte response to β-adrenergic stimulation in the metabolic syndrome. BMC Cardiovasc Disord (2013) 0.75

The growing burden of cardiovascular disease. Eur Heart J (2012) 0.75

The amiodarone derivative KB130015 [2-methyl-3-(3,5-diiodo-4-carboxymethoxybenzyl)benzofuran] induces an Na+-dependent increase of [Ca2+] in ventricular myocytes. J Pharmacol Exp Ther (2005) 0.75

FKBP12.6 overexpression does not protect against remodelling after myocardial infarction. Exp Physiol (2012) 0.75

Highlights of the 2006 scientific sessions of the European Society of Cardiology: Barcelona, Spain, September 2-5, 2006. J Am Coll Cardiol (2006) 0.75

Histological correlate of a cardiac magnetic resonance imaged microvascular obstruction in a porcine model of ischemia-reperfusion. Cardiovasc Pathol (2011) 0.75